ORLANDO, Fla.–(BUSINESS WIRE)–Aug 16, 2021–
LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the H.C. Wainwright Ophthalmology Virtual Conference on August 17, 2021.
Mr. Curtis’ presentation will be available on-demand beginning at 7:00 a.m. Eastern Time on August 17, 2021 and can be accessed through the Investors section of the Company’s website at https://ir.lensar.com. The webcast will be available for one month after the presentation has been posted.
LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210816005076/en/
CONTACT: Thomas R. Staab, II, CFO
Lee Roth / Cameron Radinovic
Burns McClellan for LENSAR
KEYWORD: UNITED STATES NORTH AMERICA FLORIDA
INDUSTRY KEYWORD: OPTICAL SURGERY GENERAL HEALTH HEALTH FDA MEDICAL DEVICES INFECTIOUS DISEASES OTHER HEALTH
SOURCE: LENSAR, Inc.
Copyright Business Wire 2021.
PUB: 08/16/2021 08:00 AM/DISC: 08/16/2021 08:02 AM